Tags

Type your tag names separated by a space and hit enter

Enantioseparations of basic and bifunctional pharmaceuticals by capillary electrochromatography using polysaccharide stationary phases.
Electrophoresis. 2003 Aug; 24(15):2567-76.E

Abstract

A fast screening strategy was developed in capillary electrochromatography (CEC) for the chiral separation of basic and bifunctional compounds. The screening conditions were determined on polysaccharide chiral stationary phases using 15 pharmaceutical compounds. The content and type of organic modifier, as well as the pH of the mobile phase appeared to have the largest influence on the chiral resolution. It was seen that for acidic compounds, our approach was not suitable. A generic mobile phase for basic and bifunctional compounds was determined. The testing on 20 additional compounds showed that the proposed mobile phase performed well since enantioselectivity was observed for 86% of the investigated compounds. A comparison of CEC and reversed-phase liquid chromatography (RPLC) results was attempted to demonstrate the potential of the used technique for chiral method development.

Authors+Show Affiliations

Department of Pharmaceutical and Biomedical Analysis, Pharmaceutical Institute, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12900869

Citation

Mangelings, Debby, et al. "Enantioseparations of Basic and Bifunctional Pharmaceuticals By Capillary Electrochromatography Using Polysaccharide Stationary Phases." Electrophoresis, vol. 24, no. 15, 2003, pp. 2567-76.
Mangelings D, Hardies N, Maftouh M, et al. Enantioseparations of basic and bifunctional pharmaceuticals by capillary electrochromatography using polysaccharide stationary phases. Electrophoresis. 2003;24(15):2567-76.
Mangelings, D., Hardies, N., Maftouh, M., Suteu, C., Massart, D. L., & Vander Heyden, Y. (2003). Enantioseparations of basic and bifunctional pharmaceuticals by capillary electrochromatography using polysaccharide stationary phases. Electrophoresis, 24(15), 2567-76.
Mangelings D, et al. Enantioseparations of Basic and Bifunctional Pharmaceuticals By Capillary Electrochromatography Using Polysaccharide Stationary Phases. Electrophoresis. 2003;24(15):2567-76. PubMed PMID: 12900869.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Enantioseparations of basic and bifunctional pharmaceuticals by capillary electrochromatography using polysaccharide stationary phases. AU - Mangelings,Debby, AU - Hardies,Nancy, AU - Maftouh,Mohamed, AU - Suteu,Christina, AU - Massart,D Luc, AU - Vander Heyden,Yvan, PY - 2003/8/6/pubmed PY - 2004/6/18/medline PY - 2003/8/6/entrez SP - 2567 EP - 76 JF - Electrophoresis JO - Electrophoresis VL - 24 IS - 15 N2 - A fast screening strategy was developed in capillary electrochromatography (CEC) for the chiral separation of basic and bifunctional compounds. The screening conditions were determined on polysaccharide chiral stationary phases using 15 pharmaceutical compounds. The content and type of organic modifier, as well as the pH of the mobile phase appeared to have the largest influence on the chiral resolution. It was seen that for acidic compounds, our approach was not suitable. A generic mobile phase for basic and bifunctional compounds was determined. The testing on 20 additional compounds showed that the proposed mobile phase performed well since enantioselectivity was observed for 86% of the investigated compounds. A comparison of CEC and reversed-phase liquid chromatography (RPLC) results was attempted to demonstrate the potential of the used technique for chiral method development. SN - 0173-0835 UR - https://www.unboundmedicine.com/medline/citation/12900869/Enantioseparations_of_basic_and_bifunctional_pharmaceuticals_by_capillary_electrochromatography_using_polysaccharide_stationary_phases_ DB - PRIME DP - Unbound Medicine ER -